Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kocabas, G. Tezcagirir, G. Seydaoglu, E. Ozyilmaz (Adana, Turkey). The relationship between comorbidities and systemic inflammation in patients with COPD. Eur Respir J 2011; 38: Suppl. 55, 4057

Member's Comments

No comment yet.

Related content which might interest you: The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Are there gender differences of systemic inflammatory state in COPD patients? Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Systemic inflammation in patients with COPD and anemia of chronic disease Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 COPD as a systemic disease Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The impact of vaccination on the dynamics of bronchial and systemic inflammation in patients with COPD and CHD Source: International Congress 2017 – COPD management Year: 2017 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013